Literature DB >> 16034184

Molecular pharmacology of gonadotropins.

Robert K Campbell1.   

Abstract

Gonadotropins have been studied in biological systems for decades and many of their properties are well defined. These include pharmacological properties such as affinity, stability, and pharmacokinetics also used to characterize drugs. Technologies applied to research on gonadotropins have led to the creation of hormone analogs with alterations to one or more of these proper-ties. Some of these analogs have potential therapeutic applications. A challenge to realizing this potential is the accurate prediction of how these compounds will perform in humans. This could be facilitated by advances in biological models and the understanding of specific effects of the hormones on their receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034184     DOI: 10.1385/ENDO:26:3:291

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  63 in total

Review 1.  Molecular, structural, and cellular biology of follitropin and follitropin receptor.

Authors:  James A Dias; Brian D Cohen; Barbara Lindau-Shepard; Cheryl A Nechamen; Andrew J Peterson; Anja Schmidt
Journal:  Vitam Horm       Date:  2002       Impact factor: 3.421

2.  Synthetic peptides based upon a three-dimensional model for the receptor recognition site of follicle-stimulating hormone exhibit antagonistic or agonistic activity at low concentrations.

Authors:  M Hage-van Noort; W C Puijk; H H Plasman; D Kuperus; W M Schaaper; N J Beekman; J A Grootegoed; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Small molecule biaryl FSH receptor agonists. Part 1: Lead discovery via encoded combinatorial synthesis.

Authors:  Tao Guo; Anton E P Adang; Roland E Dolle; Guizhen Dong; Dan Fitzpatrick; Peng Geng; Koc-Kan Ho; Steven G Kultgen; Ruiyan Liu; Edward McDonald; Brian F McGuinness; Kurt W Saionz; Kenneth J Valenzano; Nicole C R van Straten; Dan Xie; Maria L Webb
Journal:  Bioorg Med Chem Lett       Date:  2004-04-05       Impact factor: 2.823

4.  Action of PMSG and asialo-PMSG on rat Leydig and granulosa cells.

Authors:  W R Moyle; G Erickson; O P Bahl; S Christakos; J Gutowski
Journal:  Am J Physiol       Date:  1978-08

5.  Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family.

Authors:  K C McFarland; R Sprengel; H S Phillips; M Köhler; N Rosemblit; K Nikolics; D L Segaloff; P H Seeburg
Journal:  Science       Date:  1989-08-04       Impact factor: 47.728

6.  Effects of long-acting recombinant human follicle-stimulating hormone analogs containing N-linked glycosylation on murine folliculogenesis.

Authors:  Jane I Ruman; Susan Pollak; Rhonda K Trousdale; Jeffrey Klein; Joyce W Lustbader
Journal:  Fertil Steril       Date:  2005-04       Impact factor: 7.329

7.  The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women.

Authors:  P E Patton; F O Calvo; V Y Fujimoto; E R Bergert; R D Kempers; R J Ryan
Journal:  Fertil Steril       Date:  1988-04       Impact factor: 7.329

8.  Conversion of human choriogonadotropin into a follitropin by protein engineering.

Authors:  R K Campbell; D M Dean-Emig; W R Moyle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

9.  Co-evolution of ligand-receptor pairs.

Authors:  W R Moyle; R K Campbell; R V Myers; M P Bernard; Y Han; X Wang
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

10.  Development and characterization of a long-acting recombinant hFSH agonist.

Authors:  J Klein; L Lobel; S Pollak; B Lustbader; R T Ogden; M V Sauer; J W Lustbader
Journal:  Hum Reprod       Date:  2003-01       Impact factor: 6.918

View more
  1 in total

Review 1.  Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.

Authors:  Rogério de Barros F Leão; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.